Efforts are underway to retarget oncolytic RNA-based virus vectors to tumors cells with elevated expression of EGFR and the constitutively active EGFRvIII mutant associated with poor prognosis in multiple human cancers particularly glioblastoma multiforme (GBM) (Gan et al., 2013). The gene discussed is EGFR; the disease is glioblastoma.